The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials

Background: This study aims to assess the clinical efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression in adult patients through meta-analysis. Methods: The PubMed, Embase, Cochrane Library, Clinical Trials, EU Clinical Trials Register, and International Clinical T...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Jingyue, Sheng, Dandan, Lin, Fei, Jiang, Peng, Shi, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248018/
https://www.ncbi.nlm.nih.gov/pubmed/37305548
http://dx.doi.org/10.3389/fphar.2023.1157251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248018/
https://www.ncbi.nlm.nih.gov/pubmed/37305548
http://dx.doi.org/10.3389/fphar.2023.1157251

Ejemplares similares